Acyline oral - Merrion
Alternative Names: GnRH antagonist - Merrion; MER-104Latest Information Update: 02 Oct 2021
At a glance
- Originator Merrion Pharmaceuticals
- Class Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 13 Feb 2009 Clinical development is ongoing in USA
- 30 Jun 2007 Phase-I clinical trials in Prostate cancer in USA (PO)
- 27 Feb 2007 Preclinical trials in Prostate cancer in USA (PO)